サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1564997

ヒト肝臓モデルの世界市場

Human Liver Models

出版日
ページ情報
英文 194 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
ヒト肝臓モデルの世界市場
出版日: 2024年10月04日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ヒト肝臓モデルの世界市場は2030年までに4億7,420万米ドルに達する見込み

2023年に2億5,190万米ドルと推定されるヒト肝臓モデルの世界市場は、2023～2030年の分析期間でCAGR 9.5%で成長し、2030年には4億7,420万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである創薬アプリケーションは、CAGR 9.3％を記録し、分析期間終了時には2億2,580万米ドルに達すると予測されます。教育アプリケーション分野の成長率は、分析期間中CAGR 10.6％と推定されます。

米国市場は6,810万米ドルと推定、中国はCAGR13.3％で成長すると予測

米国のヒト肝臓モデル市場は、2023年に6,810万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに1億460万米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは13.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ6.8%と7.5%と予測されています。欧州では、ドイツがCAGR 7.3%で成長すると予測されています。

世界のヒト肝臓モデル市場- 主要動向と促進要因のまとめ

ヒト肝臓モデルは医薬品開発、疾患研究、毒性試験の未来となるのでしょうか？

ヒト肝臓モデルは生物医学研究において不可欠なツールとして登場しましたが、なぜ医薬品開発、疾患研究、毒性試験を進める上で不可欠なのでしょうか？ヒト肝臓モデルとは、ヒトの肝臓の構造や機能を模倣した、レバーオンチップ、3Dバイオプリント肝組織、オルガノイド、細胞培養モデルなどの試験管内システムのことです。これらのモデルにより、科学者は動物モデルやヒト臨床試験に頼ることなく、肝機能、薬物代謝、肝疾患、毒物学的影響を研究することができます。

ヒト肝臓モデルの重要性は、肝機能や疾患メカニズムの研究に、より正確でヒトに関連したデータを提供できる点にあります。従来の動物モデルは、ヒトの生物学を正確に表現できないことが多く、医薬品開発や毒性学に問題を引き起こしています。ヒト肝臓モデルは、薬剤の有効性、肝毒性、代謝プロセスについて、より正確な試験を可能にする強力な代替手段を提供します。個別化医療、バイオテクノロジー、製薬産業が拡大する中、ヒト肝臓モデルは創薬の精度を高め、動物実験への依存を減らし、肝疾患をより深く理解するために不可欠です。

技術はどのようにヒト肝臓モデルを進歩させたのか？

技術の進歩は、ヒト肝臓モデルの開発と機能性を著しく向上させ、様々な生物医学的応用のための精度と汎用性を高めました。最も重要なブレークスルーの一つは、肝臓のダイナミックな環境を模倣したマイクロ流体デバイスを使用して、小型化された肝臓システムを作成する、liver-on-a-chip技術の出現です。このチップには、生きたヒト肝細胞と血流を再現するマイクロ流路が含まれており、非常に現実的な肝生理モデルを提供します。この技術により、研究者は肝臓が薬物や毒素をどのように代謝するかを制御された環境で研究することができ、医薬品開発のためのより予測的なデータを得ることができます。

3Dバイオプリンティングもまた、ヒト肝臓モデルを前進させる革新的な技術です。肝細胞やその他の生体材料から作られたバイオインクを使用することで、科学者たちは、人間の肝臓と同じ複雑な構造を持つ肝臓組織を印刷することができるようになった。この3Dバイオプリント肝組織は、肝臓の微細構造をよりよく表現し、試験管内研究の精度を向上させる。肝組織をバイオプリントできるようになったことで、患者固有の肝モデルを作成する道も開かれ、個別化薬剤試験や疾患モデリングに利用できるようになり、医師が個人の肝臓が特定の治療にどのように反応するかを予測するのに役立ちます。

オルガノイド技術は、ヒト肝臓モデルにも革命をもたらしました。肝臓オルガノイドは、幹細胞由来の自己組織化する小型の3D構造体であり、肝臓の主要な機能の多くを再現します。これらのオルガノイドは、肝再生、疾患進行、薬物代謝を研究するための貴重なプラットフォームを提供します。特に、肝炎や非アルコール性脂肪性肝疾患（NAFLD）などの肝疾患をモデル化し、よりヒトに近い系で新薬の効果を検証するのに有用です。オルガノイドはまた、再生医療における可能性も秘めています。いつか、損傷した肝組織の修復や置換に使われるかもしれないからです。

幹細胞技術の向上、特に人工多能性幹細胞（iPSC）の利用は、個別化肝臓モデルの開発を促進しました。iPSCは患者自身の細胞から誘導され、肝細胞（肝細胞）に分化させることができるため、患者と遺伝的に同一の肝臓モデルを作成することができます。このようなパーソナライズされた肝臓モデルによって、個々の患者の反応を反映した薬剤スクリーニングや毒性試験が可能になり、よりオーダーメイドで正確な薬剤開発ができるようになります。

もう一つの進歩は、肝臓モデル研究における人工知能（AI）と機械学習の統合です。AIアルゴリズムは、肝臓モデルから得られた大規模なデータセットを解析し、研究者にとっては明らかでない薬物代謝や疾患進行のパターンを特定することができます。また、AIを搭載したツールは、肝オンチップシステムの設計を最適化したり、モデルの反応に基づいて薬物治療の結果を予測したりすることができ、調査方法をさらに加速することができます。

なぜヒト肝臓モデルが医薬品開発と疾患研究に不可欠なのか？

ヒト肝臓モデルは、薬物や疾患が肝臓とどのように相互作用するかを理解するための、より正確でヒトに関連したプラットフォームを提供するため、薬物開発、疾患研究、毒物学的検査に不可欠です。肝臓は薬物や毒物の代謝において中心的な役割を担っており、薬物の安全性試験において重要な焦点となっています。従来の動物モデルでは、生物種によって代謝が大きく異なるため、ヒトの肝臓が新薬にどのように反応するかを予測できないことが多いです。一方、ヒト肝臓モデルは、ヒトの肝機能の細胞学的、生理学的特徴を再現しており、薬物の代謝、有効性、潜在的毒性について、より正確なデータを提供します。

ヒト肝臓モデルの最も重要な用途のひとつは、前臨床薬物試験です。新薬が臨床試験に入る前に、その安全性と有効性、特に肝機能との関連性をテストする必要があります。ヒト肝臓モデルにより、研究者は薬がどのように代謝されるか、肝臓に毒性があるかどうかを評価することができ、研究開発の初期段階で潜在的な問題を特定することができます。これにより、後期臨床試験で予期せぬ肝毒性により薬剤が失敗する可能性が低くなり、製薬会社の時間、リソース、コストを節約することができます。

ヒト肝臓モデルはまた、肝炎、肝硬変、肝がんなどの肝疾患の研究にも非常に有用です。レバーオンチップシステム、3Dバイオプリント組織、またはオルガノイドを使用することにより、研究者は試験管内で肝疾患の状態を再現することができ、疾患のメカニズム、進行、および潜在的な治療法を研究することができます。これらのモデルは、肝疾患が細胞レベルで肝機能にどのような影響を与えるかについての洞察を提供し、より効果的な治療法の開発に役立ちます。例えば、肝炎の抗ウイルス薬の試験や、肝臓がんの新しい治療法の有効性を調べるために、肝臓モデルを使用することができます。

毒性試験もまた、ヒト肝臓モデルが重要な役割を果たす分野です。多くの化学物質や環境毒素は肝臓に有害な影響を及ぼし、肝障害や肝不全などの症状を引き起こします。ヒト肝臓モデルは、従来の動物実験に比べ、より安全で倫理的な方法で様々な物質の毒性を調べることができます。これらのモデルは化学物質のハイスループットスクリーニングを可能にし、研究者はどの化合物が安全で、どの化合物が肝臓の健康にリスクをもたらすかを迅速かつ効率的に決定することができます。

個別化医療もまた、ヒト肝臓モデルの使用から恩恵を受けています。患者自身の細胞から肝臓モデルを作成することにより、ヘルスケアプロバイダーは、治療を行う前に、患者の肝臓が特定の薬剤にどのように反応するかを調べることができます。これは、肝疾患のある患者や、化学療法など肝機能に影響を与えることが知られている治療を受けている患者にとって特に重要です。個別化された肝臓モデルは、薬物有害反応のリスクを最小限に抑え、患者がその人特有の生物学的構造に最も効果的な治療を受けられるようにするのに役立ちます。

さらに、ヒト肝臓モデルは、肝臓の修復と再生のための潜在的な治療法を探るために、再生医療に利用されています。例えば、肝臓オルガノイドやバイオプリント組織は、いつか肝臓病患者の損傷した肝組織の修復に使用され、肝移植の必要性を減らすことができるかもしれないです。これらのモデルは、新しい細胞ベースの治療法をテストし、肝細胞がどのように再生するかを理解するためのプラットフォームを提供し、慢性肝疾患患者に希望を与えます。

ヒト肝臓モデル市場の成長を促す要因は何か？

より正確な薬物検査への需要の高まり、3Dバイオプリンティングやオルガノイド技術の進歩、個別化医療への注目の高まりなど、いくつかの要因がヒト肝臓モデル市場の成長を促進しています。主な促進要因の一つは、医薬品開発におけるより多くの予測モデルの必要性です。医薬品開発のコストが上昇を続ける中、製薬会社は臨床試験における新薬の失敗率を下げる方法を模索しています。ヒト肝臓モデルは、薬剤がヒトの肝臓とどのように相互作用するかを予測するための、より信頼性の高い方法を提供し、より優れた前臨床試験と、肝毒性によるコストのかかる試験の失敗を減らすことにつながります。

動物実験に代わる代替法の推進も、市場の成長を促す重要な要因です。米国食品医薬品局（FDA）や欧州医薬品庁（EMA）などの規制機関は、動物実験に代わる試験管内モデルの使用を奨励しています。ヒト肝臓モデルより倫理的でヒトに関連した毒性試験の選択肢を提供し、研究における動物使用を減らす世界の取り組みと一致します。より倫理的な試験方法へのシフトは、毒性試験における肝臓モデルのさらなる採用を促進すると予想されます。

3Dバイオプリンティングやオルガノイド技術の進歩も、ヒト肝臓モデル市場の成長に寄与しています。これらの技術により、研究者はヒト肝臓の複雑さを忠実に再現した、より洗練された機能的な肝臓モデルを作成することができます。肝組織を3Dプリントしたり、幹細胞から肝臓オルガノイドを培養したりする能力は、肝疾患、薬物代謝、肝再生などの研究に新たな可能性をもたらします。これらの技術が進化を続けるにつれ、研究や医薬品開発により広く用いられるようになると予想されます。

個別化医療の台頭も重要な推進力です。ヘルスケアがより個別化された治療計画に向かうにつれ、特定の患者が薬剤にどのように反応するかを予測できるモデルの必要性が高まっています。患者由来の細胞から作成されたヒト肝臓モデルによって、研究者は患者の肝機能に対する薬剤の効果を調べることができ、よりオーダーメイドで効果的な治療法を提供することができます。この動向は、腫瘍学や肝疾患などの分野で特に顕著であり、患者固有の肝臓モデルを用いることで、治療計画を最適化し、薬物有害反応のリスクを低減することができます。

非アルコール性脂肪性肝疾患（NAFLD）、肝硬変、肝がんなどの肝疾患の有病率の増加も、より優れた肝臓モデルの需要を促進しています。肝疾患の世界の負担が増加するにつれ、研究者が新しい治療法を開発し、疾患メカニズムをより深く理解するのに役立つ正確なモデルの必要性が高まっています。ヒト肝臓モデルは、肝疾患を研究するためのより適切で正確なツールを提供し、患者の予後を改善する治療法の開発を加速します。

バイオプリンティング、オルガノイド技術、個別化医療の進歩に伴い、ヒト肝臓モデル市場は大きな成長を遂げようとしています。より正確で倫理的、かつヒトに関連した試験方法に対する要求が高まる中、ヒト肝臓モデルは、医薬品開発を促進し、疾患研究を改善し、毒性研究における動物実験への依存を低減するための重要なツールであり続けるでしょう。

調査対象企業の例（全 42社）

  • BioIVT, LLC.
  • Charles River Laboratories International, Inc.
  • CN Bio Innovations Ltd.
  • Crown Bioscience, Inc.
  • Cyfuse Biomedical K.K.
  • Emulate, Inc.
  • Mimetas
  • Organovo Holdings, Inc.
  • Taconic Biosciences, Inc.
  • Yecuris

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP12452

Global Human Liver Models Market to Reach US$474.2 Million by 2030

The global market for Human Liver Models estimated at US$251.9 Million in the year 2023, is expected to reach US$474.2 Million by 2030, growing at a CAGR of 9.5% over the analysis period 2023-2030. Drug Discovery Application, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$225.8 Million by the end of the analysis period. Growth in the Educational Application segment is estimated at 10.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$68.1 Million While China is Forecast to Grow at 13.3% CAGR

The Human Liver Models market in the U.S. is estimated at US$68.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$104.6 Million by the year 2030 trailing a CAGR of 13.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.8% and 7.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.3% CAGR.

Global Human Liver Models Market - Key Trends and Drivers Summarized

Are Human Liver Models the Future of Drug Development, Disease Research, and Toxicology Testing?

Human liver models have emerged as a vital tool in biomedical research, but why are they so essential for advancing drug development, disease research, and toxicology testing? Human liver models refer to in vitro systems, such as liver-on-a-chip, 3D bioprinted liver tissues, organoids, and cell culture models, that mimic the structure and function of the human liver. These models allow scientists to study liver function, drug metabolism, liver diseases, and toxicological effects without relying on animal models or human clinical trials.

The importance of human liver models lies in their ability to provide more accurate and human-relevant data for studying liver function and disease mechanisms. Traditional animal models often fail to accurately represent human biology, leading to issues in drug development and toxicology. Human liver models offer a powerful alternative, allowing for more precise testing of drug efficacy, liver toxicity, and metabolic processes. As personalized medicine, biotechnology, and pharmaceutical industries expand, human liver models are critical for improving the accuracy of drug discovery, reducing reliance on animal testing, and better understanding liver diseases.

How Has Technology Advanced Human Liver Models?

Technological advancements have significantly improved the development and functionality of human liver models, making them more accurate and versatile for various biomedical applications. One of the most significant breakthroughs is the advent of liver-on-a-chip technology, where miniaturized liver systems are created using microfluidic devices that mimic the dynamic environment of the liver. These chips contain live human liver cells and microchannels that replicate blood flow, providing a highly realistic model of liver physiology. This technology allows researchers to study how the liver metabolizes drugs and toxins in a controlled environment, delivering more predictive data for drug development.

3D bioprinting is another transformative technology advancing human liver models. Using bioinks made from liver cells and other biological materials, scientists can now print liver tissues with the same complex structure as a human liver. These 3D bioprinted liver tissues provide a better representation of the liver's microarchitecture, improving the accuracy of in vitro studies. The ability to bioprint liver tissues also opens the door for creating patient-specific liver models, which can be used for personalized drug testing and disease modeling, helping doctors predict how an individual’s liver will respond to specific treatments.

Organoid technology has also revolutionized human liver models. Liver organoids are miniature, self-organizing 3D structures derived from stem cells that replicate many of the liver's key functions. These organoids provide a valuable platform for studying liver regeneration, disease progression, and drug metabolism. They are especially useful for modeling liver diseases, such as hepatitis or non-alcoholic fatty liver disease (NAFLD), and testing the effects of new drugs in a more human-like system. Organoids also have potential in regenerative medicine, as they could one day be used to repair or replace damaged liver tissues.

Improvements in stem cell technologies, particularly the use of induced pluripotent stem cells (iPSCs), have enhanced the development of personalized liver models. iPSCs can be derived from a patient’s own cells and then differentiated into liver cells (hepatocytes), offering the ability to create liver models that are genetically identical to the patient. These personalized liver models allow for drug screening and toxicity testing that reflects individual patient responses, making drug development more tailored and precise.

Another advancement is the integration of artificial intelligence (AI) and machine learning in liver model research. AI algorithms can analyze large datasets from liver models, identifying patterns in drug metabolism or disease progression that may not be obvious to researchers. AI-powered tools can also optimize the design of liver-on-a-chip systems or predict the outcomes of drug treatments based on the model’s response, further accelerating the research process.

Why Are Human Liver Models Critical for Drug Development and Disease Research?

Human liver models are critical for drug development, disease research, and toxicology testing because they provide a more accurate and human-relevant platform for understanding how drugs and diseases interact with the liver. The liver plays a central role in metabolizing drugs and toxins, making it a key focus in drug safety testing. Traditional animal models often fail to predict how a human liver will respond to new drugs due to significant differences in metabolism between species. Human liver models, on the other hand, replicate the cellular and physiological characteristics of human liver function, providing more accurate data on drug metabolism, efficacy, and potential toxicity.

One of the most important applications of human liver models is in preclinical drug testing. Before a new drug can enter clinical trials, it must be tested for its safety and effectiveness, particularly in relation to liver function. Human liver models allow researchers to assess how a drug will be metabolized and whether it has any toxic effects on the liver, helping to identify potential issues early in the development process. This reduces the likelihood of drugs failing in late-stage clinical trials due to unforeseen liver toxicity, saving time, resources, and costs for pharmaceutical companies.

Human liver models are also invaluable for studying liver diseases, such as hepatitis, cirrhosis, and liver cancer. By using liver-on-a-chip systems, 3D bioprinted tissues, or organoids, researchers can recreate the conditions of liver diseases in vitro, enabling them to study disease mechanisms, progression, and potential treatments. These models provide insights into how liver diseases affect liver function at the cellular level, helping to develop more effective therapies. For instance, liver models can be used to test antiviral drugs for hepatitis or investigate the efficacy of new treatments for liver cancer.

Toxicology testing is another critical area where human liver models play a crucial role. Many chemicals and environmental toxins can have harmful effects on the liver, leading to conditions such as liver damage or failure. Human liver models provide a safer, more ethical way to test the toxicity of various substances compared to traditional animal testing. These models allow for high-throughput screening of chemicals, enabling researchers to quickly and efficiently determine which compounds are safe and which pose risks to liver health.

Personalized medicine is also benefiting from the use of human liver models. By creating liver models derived from a patient’s own cells, healthcare providers can test how a patient’s liver will respond to specific drugs before administering treatment. This is particularly important for patients with liver diseases or those undergoing treatments that are known to impact liver function, such as chemotherapy. Personalized liver models help to minimize the risk of adverse drug reactions and ensure that patients receive the most effective treatments for their unique biological makeup.

In addition, human liver models are being used in regenerative medicine to explore potential therapies for liver repair and regeneration. For example, liver organoids and bioprinted tissues could one day be used to repair damaged liver tissue in patients with liver disease, reducing the need for liver transplants. These models provide a platform for testing new cell-based therapies and understanding how liver cells regenerate, offering hope for patients with chronic liver conditions.

What Factors Are Driving the Growth of the Human Liver Model Market?

Several factors are driving the growth of the human liver model market, including the increasing demand for more accurate drug testing, advancements in 3D bioprinting and organoid technologies, and the growing focus on personalized medicine. One of the primary drivers is the need for more predictive models in drug development. As the cost of drug development continues to rise, pharmaceutical companies are looking for ways to reduce the failure rate of new drugs in clinical trials. Human liver models offer a more reliable method for predicting how drugs will interact with the human liver, leading to better preclinical testing and fewer costly trial failures due to liver toxicity.

The push for alternatives to animal testing is another significant factor driving market growth. Regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), are encouraging the use of in vitro models as alternatives to animal testing. Human liver models provide a more ethical and human-relevant option for toxicity testing, aligning with global efforts to reduce animal use in research. This shift toward more ethical testing methods is expected to drive further adoption of liver models in toxicology testing.

Advancements in 3D bioprinting and organoid technologies are also contributing to the growth of the human liver model market. These technologies allow researchers to create more sophisticated and functional liver models that closely replicate the complexity of the human liver. The ability to print 3D liver tissues or grow liver organoids from stem cells opens up new possibilities for studying liver diseases, drug metabolism, and liver regeneration. As these technologies continue to evolve, they are expected to become more widely used in research and drug development.

The rise of personalized medicine is another key driver. As healthcare moves toward more individualized treatment plans, there is a growing need for models that can predict how specific patients will respond to drugs. Human liver models created from patient-derived cells enable researchers to test the effects of drugs on a patient’s liver function, providing more tailored and effective treatment options. This trend is particularly strong in fields such as oncology and liver disease, where patient-specific liver models can be used to optimize treatment plans and reduce the risk of adverse drug reactions.

The increasing prevalence of liver diseases, such as non-alcoholic fatty liver disease (NAFLD), cirrhosis, and liver cancer, is also driving demand for better liver models. As the global burden of liver disease rises, there is a growing need for accurate models that can help researchers develop new therapies and better understand disease mechanisms. Human liver models provide a more relevant and precise tool for studying liver diseases, accelerating the development of treatments that can improve patient outcomes.

With advancements in bioprinting, organoid technologies, and personalized medicine, the human liver model market is poised for significant growth. As the demand for more accurate, ethical, and human-relevant testing methods increases, human liver models will remain a key tool for advancing drug development, improving disease research, and reducing reliance on animal testing in toxicology studies.

Select Competitors (Total 42 Featured) -

  • BioIVT, LLC.
  • Charles River Laboratories International, Inc.
  • CN Bio Innovations Ltd.
  • Crown Bioscience, Inc.
  • Cyfuse Biomedical K.K.
  • Emulate, Inc.
  • Mimetas
  • Organovo Holdings, Inc.
  • Taconic Biosciences, Inc.
  • Yecuris

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Human Liver Models - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Drug Discovery and Toxicity Testing Drives Growth in Human Liver Models Market
    • Technological Advancements in 3D Bioprinting and Organ-on-a-chip Propel Innovation in Liver Models
    • Growth in Use of Human Liver Models for Preclinical Trials Expands Addressable Market
    • Increasing Focus on In Vitro Alternatives to Animal Testing Fuels Demand for Human Liver Models
    • Growth in Use of Human Liver Models in Hepatotoxicity and Disease Modeling Expands Market Opportunities
    • Increasing Focus on Stem Cell-derived Liver Models for Regenerative Medicine Expands Market Reach
    • Technological Advancements in Microfluidics and 3D Scaffold-free Models Drive Market Innovation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Human Liver Models Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Human Liver Models by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Human Liver Models by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Human Liver Models by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Educational by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Educational by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Educational by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Liver Organoids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Liver Organoids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Liver Organoids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Liver-on-a-chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Liver-on-a-chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Liver-on-a-chip by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for 3D Bioprinting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for 3D Bioprinting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for 3D Bioprinting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for 2D Models by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for 2D Models by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for 2D Models by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Human Liver Models Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Human Liver Models by Application - Drug Discovery, Educational and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Human Liver Models by Application - Drug Discovery, Educational and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Human Liver Models by Application - Percentage Breakdown of Value Sales for Drug Discovery, Educational and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Human Liver Models by Application - Drug Discovery, Educational and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Human Liver Models by Application - Drug Discovery, Educational and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Human Liver Models by Application - Percentage Breakdown of Value Sales for Drug Discovery, Educational and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types for the Years 2014, 2024 & 2030
  • JAPAN
    • Human Liver Models Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Human Liver Models by Application - Drug Discovery, Educational and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Human Liver Models by Application - Drug Discovery, Educational and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Human Liver Models by Application - Percentage Breakdown of Value Sales for Drug Discovery, Educational and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types for the Years 2014, 2024 & 2030
  • CHINA
    • Human Liver Models Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Human Liver Models by Application - Drug Discovery, Educational and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Human Liver Models by Application - Drug Discovery, Educational and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Human Liver Models by Application - Percentage Breakdown of Value Sales for Drug Discovery, Educational and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types for the Years 2014, 2024 & 2030
  • EUROPE
    • Human Liver Models Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Human Liver Models by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Human Liver Models by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Human Liver Models by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Human Liver Models by Application - Drug Discovery, Educational and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Human Liver Models by Application - Drug Discovery, Educational and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Human Liver Models by Application - Percentage Breakdown of Value Sales for Drug Discovery, Educational and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types for the Years 2014, 2024 & 2030
  • FRANCE
    • Human Liver Models Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Human Liver Models by Application - Drug Discovery, Educational and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Human Liver Models by Application - Drug Discovery, Educational and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Human Liver Models by Application - Percentage Breakdown of Value Sales for Drug Discovery, Educational and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types for the Years 2014, 2024 & 2030
  • GERMANY
    • Human Liver Models Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Human Liver Models by Application - Drug Discovery, Educational and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Human Liver Models by Application - Drug Discovery, Educational and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Human Liver Models by Application - Percentage Breakdown of Value Sales for Drug Discovery, Educational and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Human Liver Models by Application - Drug Discovery, Educational and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Human Liver Models by Application - Drug Discovery, Educational and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Human Liver Models by Application - Percentage Breakdown of Value Sales for Drug Discovery, Educational and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Human Liver Models Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Human Liver Models by Application - Drug Discovery, Educational and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Human Liver Models by Application - Drug Discovery, Educational and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Human Liver Models by Application - Percentage Breakdown of Value Sales for Drug Discovery, Educational and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Human Liver Models by Application - Drug Discovery, Educational and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Human Liver Models by Application - Drug Discovery, Educational and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Human Liver Models by Application - Percentage Breakdown of Value Sales for Drug Discovery, Educational and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Human Liver Models by Application - Drug Discovery, Educational and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Human Liver Models by Application - Drug Discovery, Educational and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Human Liver Models by Application - Percentage Breakdown of Value Sales for Drug Discovery, Educational and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Human Liver Models by Application - Drug Discovery, Educational and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Human Liver Models by Application - Drug Discovery, Educational and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Human Liver Models by Application - Percentage Breakdown of Value Sales for Drug Discovery, Educational and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Human Liver Models Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Human Liver Models by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Human Liver Models by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Human Liver Models by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Human Liver Models by Application - Drug Discovery, Educational and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Human Liver Models by Application - Drug Discovery, Educational and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Human Liver Models by Application - Percentage Breakdown of Value Sales for Drug Discovery, Educational and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Human Liver Models Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Human Liver Models by Application - Drug Discovery, Educational and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Human Liver Models by Application - Drug Discovery, Educational and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Human Liver Models by Application - Percentage Breakdown of Value Sales for Drug Discovery, Educational and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types for the Years 2014, 2024 & 2030
  • INDIA
    • Human Liver Models Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Human Liver Models by Application - Drug Discovery, Educational and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Human Liver Models by Application - Drug Discovery, Educational and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: India 16-Year Perspective for Human Liver Models by Application - Percentage Breakdown of Value Sales for Drug Discovery, Educational and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: India 16-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Human Liver Models by Application - Drug Discovery, Educational and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Human Liver Models by Application - Drug Discovery, Educational and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Human Liver Models by Application - Percentage Breakdown of Value Sales for Drug Discovery, Educational and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Human Liver Models by Application - Drug Discovery, Educational and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Human Liver Models by Application - Drug Discovery, Educational and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Human Liver Models by Application - Percentage Breakdown of Value Sales for Drug Discovery, Educational and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Human Liver Models Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Human Liver Models by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Human Liver Models by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Human Liver Models by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Human Liver Models by Application - Drug Discovery, Educational and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Human Liver Models by Application - Drug Discovery, Educational and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Human Liver Models by Application - Percentage Breakdown of Value Sales for Drug Discovery, Educational and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Human Liver Models by Application - Drug Discovery, Educational and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Human Liver Models by Application - Drug Discovery, Educational and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Human Liver Models by Application - Percentage Breakdown of Value Sales for Drug Discovery, Educational and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Human Liver Models by Application - Drug Discovery, Educational and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Human Liver Models by Application - Drug Discovery, Educational and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Human Liver Models by Application - Percentage Breakdown of Value Sales for Drug Discovery, Educational and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Human Liver Models by Application - Drug Discovery, Educational and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Human Liver Models by Application - Drug Discovery, Educational and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Human Liver Models by Application - Percentage Breakdown of Value Sales for Drug Discovery, Educational and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Human Liver Models by Application - Drug Discovery, Educational and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Human Liver Models by Application - Drug Discovery, Educational and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Human Liver Models by Application - Percentage Breakdown of Value Sales for Drug Discovery, Educational and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Human Liver Models Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Human Liver Models by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Human Liver Models by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Human Liver Models by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Human Liver Models by Application - Drug Discovery, Educational and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Human Liver Models by Application - Drug Discovery, Educational and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Human Liver Models by Application - Percentage Breakdown of Value Sales for Drug Discovery, Educational and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Human Liver Models by Application - Drug Discovery, Educational and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Human Liver Models by Application - Drug Discovery, Educational and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Human Liver Models by Application - Percentage Breakdown of Value Sales for Drug Discovery, Educational and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Human Liver Models by Application - Drug Discovery, Educational and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Human Liver Models by Application - Drug Discovery, Educational and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Human Liver Models by Application - Percentage Breakdown of Value Sales for Drug Discovery, Educational and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Human Liver Models by Application - Drug Discovery, Educational and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Human Liver Models by Application - Drug Discovery, Educational and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Human Liver Models by Application - Percentage Breakdown of Value Sales for Drug Discovery, Educational and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Human Liver Models by Application - Drug Discovery, Educational and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Human Liver Models by Application - Drug Discovery, Educational and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Human Liver Models by Application - Percentage Breakdown of Value Sales for Drug Discovery, Educational and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Human Liver Models by Application - Drug Discovery, Educational and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Human Liver Models by Application - Drug Discovery, Educational and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Human Liver Models by Application - Percentage Breakdown of Value Sales for Drug Discovery, Educational and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types for the Years 2014, 2024 & 2030
  • AFRICA
    • Human Liver Models Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Human Liver Models by Application - Drug Discovery, Educational and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Human Liver Models by Application - Drug Discovery, Educational and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Human Liver Models by Application - Percentage Breakdown of Value Sales for Drug Discovery, Educational and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models and Other Types for the Years 2014, 2024 & 2030

IV. COMPETITION